Su Zhen bought CTMX
March 20, 2024 · Form 4 insider transaction
Su Zhen bought 76,000 shares of CytomX Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
76,000
Price
$0.00
Total value
N/A
InsiderSu Zhen
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 20, 2024
Filing dateMarch 22, 2024
Shares owned after76,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/36th of the shares subject to the option vest on each monthly anniversary measured from March 20, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.